"treatment"

Image attribution: the copyright holder of this work, release this work into the public domain. In a decisive vote on Thursday, the House of Representatives approved a Republican-led bill that seeks …

As healthcare costs rise, a new study reveals that major healthcare companies are sending nearly all their profits to investors instead of using the money to lower costs, improve services, …

The FDA has approved a new non-opioid pain medication that has the potential to significantly change pain management.  Journavx, also known as suzetrigine, is the first and only approved oral …

Researchers are raising awareness about a lesser-known but prevalent memory loss condition called limbic-predominant age-related TDP-43 encephalopathy, or LATE, which is often misdiagnosed as Alzheimer’s. A recent report in Alzheimer’s …

After 15 months of relentless conflict in the Middle East, Israel and Hamas have agreed to a cease-fire deal brokered with substantial international mediation and a pivotal push from President-elect …

The United States holds a grim distinction: it has the highest rate of drug overdose deaths among 30 countries analyzed in a recent report by the health nonprofit Commonwealth Fund. …

Israel’s conflict with Hamas has led to remarkable medical advancements, transforming healthcare both on and off the battlefield.  One example is Aaron Bours, an Israeli reservist and New York native, …

Researchers at the Murdoch Children’s Research Institute (MCRI) are developing a groundbreaking stem cell therapy that could soon help children with heart failure. Building on the pioneering work of Japanese …

New research from the United Kingdom reveals that excessive use of acetaminophen—commonly known as Tylenol—may pose significant health risks for older adults. The study highlights potential dangers for seniors who …

A recent analysis published in The Lancet reveals a sobering outlook for life expectancy in the United States over the coming decades.  According to forecasts by the University of Washington’s …